-transparent.png){kind=logo}
Cyclosporin A (CA) was used in the treatment of 2 patients with acquired aplastic anemia. Upon reaching hematological remission these children had recurrence consequent to dose lowering or discontinuation of CA. The remission occurred again when full-dose CA treatment was resumed. Slow 2-year decrease in CA dose led to uneventful end of CA treatment without deterioration of blood picture.
Related Publications
N Iu Bogacheva, and
M M Shneĭder, and
A A Maschan
January 1989,
Padiatrie und Padologie,
N Iu Bogacheva, and
M M Shneĭder, and
A A Maschan
November 1987,
Schweizerische medizinische Wochenschrift,
N Iu Bogacheva, and
M M Shneĭder, and
A A Maschan
January 1989,
Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui,
N Iu Bogacheva, and
M M Shneĭder, and
A A Maschan
May 1992,
American journal of hematology,
N Iu Bogacheva, and
M M Shneĭder, and
A A Maschan
January 1994,
Polski tygodnik lekarski (Warsaw, Poland : 1960),
N Iu Bogacheva, and
M M Shneĭder, and
A A Maschan
January 2002,
Revista da Associacao Medica Brasileira (1992),
N Iu Bogacheva, and
M M Shneĭder, and
A A Maschan
November 2021,
Pediatrics and neonatology,
N Iu Bogacheva, and
M M Shneĭder, and
A A Maschan
February 1986,
Experimental hematology,
N Iu Bogacheva, and
M M Shneĭder, and
A A Maschan
October 1981,
Schweizerische medizinische Wochenschrift,
N Iu Bogacheva, and
M M Shneĭder, and
A A Maschan
March 1995,
Pediatria polska,
